Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
Authors
Keywords
COVID-19, SARS-CoV-2, Main protease, Ebsulfur, Inhibitor
Journal
BIOORGANIC CHEMISTRY
Volume 112, Issue -, Pages 104889
Publisher
Elsevier BV
Online
2021-04-08
DOI
10.1016/j.bioorg.2021.104889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
- (2021) Ewelina Weglarz-Tomczak et al. Scientific Reports
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
- (2020) Linlin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The reproductive number of COVID-19 is higher compared to SARS coronavirus
- (2020) Ying Liu et al. JOURNAL OF TRAVEL MEDICINE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
- (2020) Aleix Gimeno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Comparison of Prevalence and Associated Factors of Anxiety and Depression Among People Affected by versus People Unaffected by Quarantine During the COVID-19 Epidemic in Southwestern China
- (2020) Lei Lei et al. MEDICAL SCIENCE MONITOR
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
- (2020) Alessandro Grottesi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural basis of RNA cap modification by SARS-CoV-2
- (2020) Thiruselvam Viswanathan et al. Nature Communications
- Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates
- (2020) Ryunosuke Yoshino et al. Scientific Reports
- Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase
- (2020) Vijay Kumar Bhardwaj et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
- (2020) Yan Lou et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants
- (2020) Rahul Singh et al. GENOMICS
- Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
- (2020) Filippo Albani et al. Journal of Clinical Medicine
- Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
- (2020) Vijay Kumar Bhardwaj et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Alina Shitrit et al. Scientific Reports
- An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2
- (2020) Jatin Sharma et al. FOOD CHEMISTRY
- Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor
- (2019) Rami Musharrafieh et al. JOURNAL OF VIROLOGY
- The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition
- (2019) Cheng Chen et al. Future Medicinal Chemistry
- Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective
- (2019) Rahul Singh et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Elimination of bitter-off taste of stevioside through structure modification and computational interventions
- (2019) Vijay Bhardwaj et al. JOURNAL OF THEORETICAL BIOLOGY
- Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors
- (2018) Yang Xiang et al. ACS Medicinal Chemistry Letters
- Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo
- (2018) Jianpeng Su et al. BIOORGANIC CHEMISTRY
- Carbamylmethyl Mercaptoacetate Thioether: A Novel Scaffold for the Development of L1 Metallo-β-lactamase Inhibitors
- (2017) Ya-Nan Chang et al. ACS Medicinal Chemistry Letters
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors
- (2016) Le Zhai et al. ACS Medicinal Chemistry Letters
- Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
- (2015) Yasuhiro Shimamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Covalent docking using autodock: Two-point attractor and flexible side chain methods
- (2015) Giulia Bianco et al. PROTEIN SCIENCE
- Diaryl-Substituted Azolylthioacetamides: Inhibitor Discovery of New Delhi Metallo-β-Lactamase-1 (NDM-1)
- (2014) Yi-Lin Zhang et al. ChemMedChem
- Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
- (2013) Pillaiyar Thanigaimalai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis
- (2011) Robert A. Copeland et al. ANALYTICAL BIOCHEMISTRY
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
- Covalent Protein Labeling Based on Noncatalytic β-Lactamase and a Designed FRET Substrate
- (2009) Shin Mizukami et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now